Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Autoimmune Disorders

Free Subscription 05.11.2018 2 BMC Neurol 1 Curr Opin Immunol 1 Diabetes Res Clin Pract 6 Intern Med 4 J Autoimmun 3 J Immunol 2 J Neuroimmunol 3 J Neurol 1 J Rheumatol 1 Kidney Int 4 Lancet 6 Mult Scler 6 Neurology 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

BMC Neurol

1. MOTATAIANU A, Maier S, Bajko Z, Voidazan S, et al
   Cardiac autonomic neuropathy in type 1 and type 2 diabetes patients.
   BMC Neurol. 2018;18:126.
   PubMed     Text format     Abstract available
   
   
2. VAKRAKOU AG, Tzanetakos D, Valsami S, Grigoriou E, et al
   A case of Alemtuzumab-induced neutropenia in multiple sclerosis in association with the expansion of large granular lymphocytes.
   BMC Neurol. 2018;18:178.
   PubMed     Text format     Abstract available
   
   

   
   Curr Opin Immunol

3. PHALKE S, Marrack P
   Age (autoimmunity) associated B cells (ABCs) and their relatives.
   Curr Opin Immunol. 2018;55:75-80.
   PubMed     Text format     Abstract available
   
   

   
   Diabetes Res Clin Pract

4. WALICKA M, Milczarczyk A, Snarski E, Jedynasty K, et al
   Lack of persistent remission following initial recovery in patients with type 1 diabetes treated with autologous peripheral blood stem cell transplantation.
   Diabetes Res Clin Pract. 2018;143:357-363.
   PubMed     Text format     Abstract available
   
   

   
   Intern Med

5. UENO T, Kimura R, Kon T, Haga R, et al
   The Differential Diagnosis of Acute Onset Truncal Ataxia: The Importance of Dysgeusia in Miller Fisher Syndrome.
   Intern Med. 2018;57:2057-2060.
   PubMed     Text format     Abstract available
   
   
6. KOIKE H, Nishi R, Ikeda S, Kawagashira Y, et al
   Restoration of a Conduction Block after the Long-term Treatment of CIDP with Anti-neurofascin 155 Antibodies: Follow-up of a Case over 23 Years.
   Intern Med. 2018;57:2061-2066.
   PubMed     Text format     Abstract available
   
   
7. SHIBA M, Inaba H, Ariyasu H, Kawai S, et al
   Fulminant Type 1 Diabetes Mellitus Accompanied by Positive Conversion of Anti-insulin Antibody after the Administration of Anti-CTLA-4 Antibody Following the Discontinuation of Anti-PD-1 Antibody.
   Intern Med. 2018;57:2029-2034.
   PubMed     Text format     Abstract available
   
   
8. FUKUDA H, Tanaka A, Hirashima Y, Ito I, et al
   Lambert-Eaton Myasthenic Syndrome Associated with Synchronous Double Cancer: A Combination of Small Cell Carcinoma of the Cervix and Breast Carcinoma.
   Intern Med. 2018;57:2409-2411.
   PubMed     Text format     Abstract available
   
   
9. KAWASAKI F, Anno T, Takai M, Irie S, et al
   Saibokuto as a Possible Therapy for Type B Insulin Resistance Syndrome: The Disappearance of Anti-insulin Receptor Antibody and a Marked Amelioration of Glycemic Control by Saibokuto Treatment.
   Intern Med. 2018;57:2359-2363.
   PubMed     Text format     Abstract available
   
   
10. ITO Y, Makita S, Maeshima AM, Hatta S, et al
    Paraneoplastic Pemphigus Associated with B-cell Chronic Lymphocytic Leukemia Treated with Ibrutinib and Rituximab.
    Intern Med. 2018;57:2395-2398.
    PubMed     Text format     Abstract available
    
    

    
    J Autoimmun

11. TERZIROLI BERETTA-PICCOLI B, Vergani D, Mieli-Vergani G
    Autoimmune sclerosing cholangitis: Evidence and open questions.
    J Autoimmun. 2018 Oct 23. pii: S0896-8411(18)30539.
    PubMed     Text format     Abstract available
    
    
12. TERZIROLI BERETTA-PICCOLI B, Mieli-Vergani G, Vergani D
    The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview.
    J Autoimmun. 2018 Oct 23. pii: S0896-8411(18)30518.
    PubMed     Text format     Abstract available
    
    
13. BAERT L, Manfroi B, Casez O, Sturm N, et al
    The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targeting.
    J Autoimmun. 2018 Oct 30. pii: S0896-8411(18)30597.
    PubMed     Text format     Abstract available
    
    
14. FLOREANI A, Restrepo-Jimenez P, Secchi MF, De Martin S, et al
    Etiopathogenesis of autoimmune hepatitis.
    J Autoimmun. 2018 Oct 29. pii: S0896-8411(18)30522.
    PubMed     Text format     Abstract available
    
    

    
    J Immunol

15. HABIBULLAH M, Porter JA, Kluger N, Ranki A, et al
    Calcium-Sensing Receptor Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1: Epitopes, Specificity, Functional Affinity, IgG Subclass, and Effects on Receptor Activity.
    J Immunol. 2018 Oct 31. pii: jimmunol.1701527. doi: 10.4049/jimmunol.1701527.
    PubMed     Text format     Abstract available
    
    
16. DU SW, Jacobs HM, Arkatkar T, Rawlings DJ, et al
    Integrated B Cell, Toll-like, and BAFF Receptor Signals Promote Autoantibody Production by Transitional B Cells.
    J Immunol. 2018 Oct 29. pii: jimmunol.1800393. doi: 10.4049/jimmunol.1800393.
    PubMed     Text format     Abstract available
    
    
17. LIN Q, Ohtsuji M, Amano H, Tsurui H, et al
    FcgammaRIIb on B Cells and Myeloid Cells Modulates B Cell Activation and Autoantibody Responses via Different but Synergistic Pathways in Lupus-Prone Yaa Mice.
    J Immunol. 2018 Oct 29. pii: jimmunol.1701487. doi: 10.4049/jimmunol.1701487.
    PubMed     Text format     Abstract available
    
    

    
    J Neuroimmunol

18. RAMIREZ GA, Coletto LA, Bozzolo EP, Citterio L, et al
    The TRPC6 intronic polymorphism, associated with the risk of neurological disorders in systemic lupus erythematous, influences immune cell function.
    J Neuroimmunol. 2018;325:43-53.
    PubMed     Text format     Abstract available
    
    
19. SAFIZADEH B, Hoshyar R, Mehrpour M, Eftekhar M, et al
    The role of expression and activity of 15-Lipoxygenase isoforms and related cytokines in patients with Multiple Sclerosis and healthy controls.
    J Neuroimmunol. 2018;325:32-42.
    PubMed     Text format     Abstract available
    
    

    
    J Neurol

20. ELLRICHMANN G, Bolz J, Peschke M, Duscha A, et al
    Peripheral CD19(+) B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders.
    J Neurol. 2018 Oct 30. pii: 10.1007/s00415-018-9092.
    PubMed     Text format     Abstract available
    
    
21. SAEZ MS, Rojas JI, Lorenzon MV, Sanchez F, et al
    Validation of CSF free light chain in diagnosis and prognosis of multiple sclerosis and clinically isolated syndrome: prospective cohort study in Buenos Aires.
    J Neurol. 2018 Nov 1. pii: 10.1007/s00415-018-9106.
    PubMed     Text format     Abstract available
    
    
22. MALLUCCI G, Annovazzi P, Miante S, Torri-Clerici V, et al
    Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre study.
    J Neurol. 2018;265:1850-1859.
    PubMed     Text format     Abstract available
    
    

    
    J Rheumatol

23. UGOLINI R, Muratore F, Salvarani C
    Cardiac and Pulmonary Artery Involvement Detected by 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Large-vessel Giant Cell Arteritis.
    J Rheumatol. 2018;45:1603-1604.
    PubMed     Text format    
    
    

    
    Kidney Int

24. BRIX SR, Noriega M, Tennstedt P, Vettorazzi E, et al
    Development and validation of a renal risk score in ANCA-associated glomerulonephritis.
    Kidney Int. 2018 Oct 23. pii: S0085-2538(18)30552.
    PubMed     Text format     Abstract available
    
    

    
    Lancet

25. FLUME PA, Chalmers JD, Olivier KN
    Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity.
    Lancet. 2018;392:880-890.
    PubMed     Text format     Abstract available
    
    
26. COSTEDOAT-CHALUMEAU N, Houssiau FA
    Ustekinumab: a promising new drug for SLE?
    Lancet. 2018;392:1284-1286.
    PubMed     Text format    
    
    
27. TAUSCHMANN M, Thabit H, Bally L, Allen JM, et al
    Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial.
    Lancet. 2018 Oct 1. pii: S0140-6736(18)31947.
    PubMed     Text format     Abstract available
    
    
28. GALDERISI A, Sherr JL
    Enlarging the loop: closed-loop insulin delivery for type 1 diabetes.
    Lancet. 2018 Oct 1. pii: S0140-6736(18)32329.
    PubMed     Text format    
    
    

    
    Mult Scler

29. PANICUCCI E, Cohen M, Bourg V, Rocher F, et al
    De novo convulsive status epilepticus in patients with multiple sclerosis treated with dalfampridine.
    Mult Scler. 2018 Oct 30:1352458518790379. doi: 10.1177/1352458518790379.
    PubMed     Text format     Abstract available
    
    
30. FARRELL R
    Clinical commentary on "De novo convulsive status epilepticus in patients with multiple sclerosis treated with dalfampridine".
    Mult Scler. 2018 Oct 30:1352458518810661. doi: 10.1177/1352458518810661.
    PubMed     Text format    
    
    
31. PEETERS LM, van Munster CE, Van Wijmeersch B, Bruyndonckx R, et al
    Multidisciplinary data infrastructures in multiple sclerosis: Why they are needed and can be done!
    Mult Scler. 2018 Nov 1:1352458518807076. doi: 10.1177/1352458518807076.
    PubMed     Text format     Abstract available
    
    
32. HEALY BC, Zurawski J, Gonzalez CT, Chitnis T, et al
    Assessment of computer adaptive testing version of the Neuro-QOL for people with multiple sclerosis.
    Mult Scler. 2018 Nov 1:1352458518810159. doi: 10.1177/1352458518810159.
    PubMed     Text format     Abstract available
    
    
33. HOBART J, Bowen A, Pepper G, Crofts H, et al
    International consensus on quality standards for brain health-focused care in multiple sclerosis.
    Mult Scler. 2018 Nov 1:1352458518809326. doi: 10.1177/1352458518809326.
    PubMed     Text format     Abstract available
    
    
34. ACHIRON A, Sarova-Pinhas I, Magalashvili D, Stern Y, et al
    Residual disability after severe relapse in people with multiple sclerosis treated with disease-modifying therapy.
    Mult Scler. 2018 Nov 1:1352458518809903. doi: 10.1177/1352458518809903.
    PubMed     Text format     Abstract available
    
    

    
    Neurology

35. LEWIS A, Galetta S
    Editors' note: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.
    Neurology. 2018;91:849.
    PubMed     Text format    
    
    
36. PROSCHMANN U, Akgun K, Ziemssen T
    Reader response: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.
    Neurology. 2018;91:849-850.
    PubMed     Text format    
    
    
37. SOTGIU S, Eusebi A, Begliuomini C, Guerini FR, et al
    Reader response: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.
    Neurology. 2018;91:850.
    PubMed     Text format    
    
    
38. PORTACCIO E, Amato MP
    Author response: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.
    Neurology. 2018;91:851.
    PubMed     Text format    
    
    
39. SOLOMON AJ, Naismith RT, Cross AH
    Misdiagnosis of multiple sclerosis: Impact of the 2017 McDonald criteria on clinical practice.
    Neurology. 2018 Oct 31. pii: WNL.0000000000006583.
    PubMed     Text format     Abstract available
    
    
40. BROWNLEE WJ
    Misdiagnosis of multiple sclerosis: If you have a hammer, everything looks like a nail?
    Neurology. 2018 Oct 31. pii: WNL.0000000000006584.
    PubMed     Text format    
    
    

    
    Proc Natl Acad Sci U S A

41. ZHANG M, Racine JJ, Lin Q, Liu Y, et al
    MHC-mismatched mixed chimerism restores peripheral tolerance of noncross-reactive autoreactive T cells in NOD mice.
    Proc Natl Acad Sci U S A. 2018;115:E2329-E2337.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: